Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VPT.Vthis companyVentriPoint Diagnostics Ltd.	CA$0.07	-7.22×	-5.63×	128.71×	-9.64×	-117.0%	66.0%	-1889.4%	-1778.6%	77.7%	222.2%	-6.7%	-0.63×	-0.96×	-6.44×	0.08×	0.0%	5	-158.92	2	C
ASG.VAurora Spine Corporation	CA$0.11	-20.7×	4.02×	0.83×	23.82×	987.9%	24.6%	-1.8%	-4.1%	-19.5%	-4.3%	2.7%	0.93×	3.51×	-1.12×	2.33×	0.0%	5	-1.78	1	D+
BLAB.CNBritannia Life Sciences Inc.	CA$0.07	1.12×	0.7×	30.75×	-9.69×	-103.5%	8.2%	-306.8%	2753.4%	63.0%	-6.6%	-7.9%	0.01×	0.79×	-57.36×	6.57×	0.0%	6	3.03	4	A+
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.11	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
MDMA.CNPharmala Biotech Holdings Inc.	CA$0.17	-6.19×	5.47×	22.2×	-6.47×	-266.4%	-139.6%	-355.6%	-359.2%	-88.5%	-87.6%	-7.8%	0×	0.02×	0×	1.71×	0.0%	2	5.56	1	D+
Peer median	—	-5.88×	0.7×	7.19×	-6.47×	-154.2%	0.0%	-78.3%	-4.1%	47.2%	-4.3%	-7.8%	0×	0.02×	-1.78×	1.71×	0.0%	3	-1.78	2	—